全球葡萄糖酸钙市场－2025-2030年预测

全球葡萄糖酸钙市场预计将从 2025 年的 127,471,000 美元成长到 2030 年的 156,023,000 美元，复合年增长率为 4.13%。

葡萄糖酸钙是一种矿物质补充剂，由葡萄糖酸与石灰或碳酸钙中和製成。它是一种重要的治疗药物，可静脉注射或其他途径给药，用于治疗多种由钙缺乏引起的疾病，包括低钙性手足搦症、副甲状腺功能副甲状腺机能亢进症相关的低血钙症、与快速生长和怀孕相关的疾病以及高镁血症。受主要终端用户产业（尤其是製药和食品饮料产业）需求成长的推动，全球葡萄糖酸钙市场预计将持续扩张。

市场成长驱动因素

钙葡萄糖酸盐市场的主要成长要素是膳食补充剂消费量的增加。钙补充剂在治疗低血钙症及其併发症等钙缺乏症方面的显着疗效巩固了市场需求。大众对骨质疏鬆症等疾病（影响着相当一部分人口）的健康意识不断提高，促使人们积极将钙补充剂纳入健康维护策略，从而推动了钙葡萄糖酸盐等产品的市场成长。

儘管看似独立，但其他矿物质补充剂（例如葡萄糖酸铜）的消费也在影响市场格局。铜在维持心率等生理功能中发挥着至关重要的作用，而铜缺乏与心臟病密切相关。随着全球心臟病病例以及其他与营养不良和维生素缺乏相关的健康问题日益增多，矿物质补充剂市场整体正在扩张。受营养匮乏的垃圾食物消费和饮食障碍率上升等因素的推动，这一趋势间接地刺激了对葡萄糖酸盐类补充剂（包括葡萄糖酸钙）的需求。

此外，主要产业参与者之间的投资和合作策略重点也是市场发展的关键驱动因素。为了在竞争激烈的经济环境中维持成长，企业正集中投资于新技术引进、原物料供应保障和产品系列优化。鑑于各国经济和社会环境的差异，製造商正在加速制定区域性策略，以有效渗透多元化的全球市场。

市场区隔分析

根据产品类别划分，预计乳酸葡萄糖酸钙将占据最大的市场份额。这种化合物是一种白色结晶质无味粉末，以其良好的生理相容性和无毒性而闻名。其优异的生物利用度、中性口感和极佳的溶解性使其成为理想之选。科学研究表明，与其他钙盐相比，它能持续显着地提高骨骼密度。这些特性使其成为医药和食品加工应用中极具价值的优质钙源，尤其是在溶解性至关重要的领域，例如透明饮料和即溶配方。

就应用领域而言，製药业是葡萄糖酸钙的主要应用领域。葡萄糖酸钙在医疗方面的益处，尤其是在治疗因生活方式改变和缺乏运动而引起的骨质疏鬆症方面，使其占据了最大的市场份额。此外，消费者对预防钙缺乏产品的需求不断增长，也是推动其在製药领域应用的关键因素。

区域展望

从区域来看，北美预计将成为全球葡萄糖酸钙的主要市场，这主要得益于该地区蓬勃发展的医疗保健产业。该地区拥有众多大型製药企业，并且生产用于治疗甲状腺疾病和佝偻病的药物，这些都是推动市场成长的具体因素。

同时，美国的战略投资项目预计将进一步推动成长。由健康基金会和科学院推出的各项倡议，旨在解决全球钙缺乏症及其对健康的影响。这些项目通常会探讨补充钙在改善健康结果（包括孕产妇健康和心血管功能）方面的作用。低钙水平与心血管疾病风险增加之间已确立的联繫，进一步凸显了补充钙的重要性，从而推动葡萄糖酸钙作为关键治疗和预防药物扩大市场份额。

本报告的主要优势：

• 深入分析：提供对主要和新兴地区的深入市场洞察，重点关注客户群、政府政策和社会经济因素、消费者偏好、行业垂直领域和其他细分市场。
• 竞争格局：了解全球主要参与者的策略倡议，并了解透过正确的策略进入市场的机会。
• 市场驱动因素与未来趋势：探讨影响市场的动态因素和关键趋势及其对未来市场发展的影响。
• 可操作的建议：利用这些见解，在动态环境中做出策略决策，并开拓新的商机和收入来源。
• 受众广泛：对Start-Ups、研究机构、顾问公司、中小企业和大型企业都很有用且经济实惠。

企业使用我们的报告做什么？

产业与市场分析、机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法规结构及影响、新产品开发、竞争情报

报告范围：

• 2022年至2024年的历史数据和2025年至2030年的预测数据
• 成长机会、挑战、供应链前景、法规结构与趋势分析
• 竞争定位、策略和市场占有率分析
• 按业务板块和地区分類的收入成长和预测评估，包括国家/地区
• 公司概况（策略、产品、财务资讯、关键发展等）

目录

第一章执行摘要

第二章 市场概览

• 市场概览
• 市场定义
• 调查范围
• 市场区隔

第三章 商业情境

• 市场驱动因素
• 市场限制
• 市场机会
• 波特五力分析
• 产业价值链分析
• 政策与法规
• 策略建议

第四章 技术展望

5. 全球葡萄糖酸钙市场（依形态划分）

• 介绍
• 固体的
• 液体

6. 全球葡萄糖酸钙市场依给药途径划分

• 介绍
• 注射
• 口服

7. 全球葡萄糖酸钙市场依应用领域划分

• 介绍
• 食品添加物
• 矿物质补充剂
• 皮肤调理剂
• 其他的

8. 全球葡萄糖酸钙市场（以最终用户划分）

• 介绍
• 食品/饮料
• 製药
• 个人护理及化妆品
• 其他的

9. 全球葡萄糖酸钙市场（按地区划分）

• 介绍
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 南美洲
  • 巴西
  • 阿根廷
  • 其他的
• 欧洲
  • 德国
  • 法国
  • 英国
  • 西班牙
  • 其他的
• 中东和非洲
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 以色列
  • 其他的
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 印尼
  • 泰国
  • 其他的

第十章 竞争格局与分析

• 主要企业和策略分析
• 市占率分析
• 合併、收购、协议和合作
• 竞争对手仪錶板

第十一章 公司简介

• Spectrum Laboratory Products, Inc.
• Thermo Fisher Scientific
• Noah Technologies Corporation
• Global Calcium Pvt Ltd
• Merck KGaA
• Tomita Pharmaceutical Co., Ltd
• Shandong Xinhong Pharmaceutical Co., Ltd
• AdvaCare Pharma
• Paul Lohmann GmbH & Co. KGaA
• Jiaan Biotech
• Fresenius Kabi

第十二章附录

• 货币
• 先决条件
• 基准年和预测年时间表
• 相关人员的主要收益
• 调查方法
• 简称

Global Calcium Gluconate Market, with a 4.13% CAGR, is projected to grow to USD 156.023 million by 2030 from USD 127.471 million in 2025.

Calcium gluconate is a mineral supplement produced through the neutralization of gluconic acid with lime or calcium carbonate. It serves as a critical therapeutic agent, administered via intravenous therapy and other methods, to treat various conditions stemming from calcium deficiencies. These include hypocalcemic tetany, hypocalcemia associated with hyperparathyroidism, conditions related to rapid growth or pregnancy, and hypermagnesemia. The global market for calcium gluconate is projected to expand, driven by rising demand from key end-use sectors, particularly the pharmaceutical and food and beverage industries.

Market Growth Drivers

A primary driver for the calcium gluconate market is the increased consumption of nutritional supplements. The well-established benefits of calcium supplementation in managing deficient conditions such as hypocalcemia and its associated complications have solidified demand. Public health awareness regarding conditions like osteoporosis, which affects a significant portion of the population, is prompting individuals to proactively incorporate calcium supplements into their health regimens, thereby driving market growth for products like calcium gluconate.

While seemingly distinct, the consumption of other mineral supplements, such as copper gluconate, also influences the market landscape. Copper plays a vital role in physiological functions, including the maintenance of heart rate, and deficiencies have been linked to cardiac illnesses. As global cases of heart disease and other health issues related to poor nutrition and vitamin deficiencies rise, the overall market for mineral supplements expands. This trend, fueled by factors like the consumption of nutrient-poor junk food and rising eating disorders, indirectly boosts the demand for gluconate-based supplements, including calcium gluconate.

Furthermore, the strategic focus of key industry players on investments and collaborations is a significant market driver. Companies are channeling investments into acquiring new technologies, securing raw material supplies, and enhancing product portfolios to sustain growth in a competitive economic climate. Recognizing the varied economic and social landscapes across different countries, manufacturers are increasingly developing region-specific strategies to effectively penetrate diverse global markets.

Market Segment Analysis

In terms of product segments, calcium lactate gluconate is anticipated to hold a maximum market share. This compound is a white, crystalline, and odorless powder known for its high physiological compatibility and non-toxic nature. Its superior bioavailability, neutral taste, and excellent solubility make it a preferred choice. Scientifically, it has been shown to increase bone mineral density more consistently and significantly than other calcium salts. These properties make it particularly valuable as a premium calcium source in pharmaceuticals and for use in food processing applications where solubility is critical, such as in clear beverages and quick-dissolve formulations.

Regarding application, the pharmaceutical industry represents a significant domain for calcium gluconate. The advantages of calcium gluconate in medical treatments, especially for managing osteoporosis driven by changing lifestyles and physical inactivity, account for its largest market share. Additionally, the rising consumer demand for products aimed at preventing calcium deficiency is a key factor propelling its use in pharmaceutical applications.

Geographical Outlook

From a regional perspective, North America is anticipated to be a key marketplace for calcium gluconate globally. The expansion of the region's robust healthcare sector is the main driver. The presence of major pharmaceutical manufacturers and the production of medications for treating conditions like thyroid problems and rickets are specific factors propelling market growth in this region.

Concurrently, strategic investment programs in the United States are anticipated to propel further growth. Initiatives launched by health foundations and scientific academies are focused on addressing global calcium deficiency and its health impacts. These programs often explore the role of calcium supplementation in improving health outcomes, including maternal health and cardiovascular function. The established link between low calcium levels and an increased risk of cardiovascular disorders further underscores the importance of supplementation, thereby contributing to the growing market share for calcium gluconate as a key therapeutic and preventive agent.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2022 to 2024 & forecast data from 2025 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation:

• GLOBAL CALCIUM GLUCONATE MARKET BY FORM TYPE
• Solid
• Liquid
• GLOBAL CALCIUM GLUCONATE MARKET BY MODE OF ADMINISTRATION
• Injectables
• Orals
• GLOBAL CALCIUM GLUCONATE MARKET BY APPLICATION
• Food Additives
• Mineral Supplements
• Skin Conditioning Agent
• Others
• GLOBAL CALCIUM GLUCONATE MARKET BY END-USER
• Food & Beverage
• Pharmaceuticals
• Personal Care & Cosmetics
• Others
• GLOBAL CALCIUM GLUCONATE MARKET BY GEOGRAPHY
• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Others
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL CALCIUM GLUCONATE MARKET BY FORM TYPE

• 5.1. Introduction
• 5.2. Solid
• 5.3. Liquid

6. GLOBAL CALCIUM GLUCONATE MARKET BY MODE OF ADMINISTRATION

• 6.1. Introduction
• 6.2. Injectables
• 6.3. Orals

7. GLOBAL CALCIUM GLUCONATE MARKET BY APPLICATION

• 7.1. Introduction
• 7.2. Food Additives
• 7.3. Mineral Supplements
• 7.4. Skin Conditioning Agent
• 7.5. Others

8. GLOBAL CALCIUM GLUCONATE MARKET BY END-USER

• 8.1. Introduction
• 8.2. Food & Beverage
• 8.3. Pharmaceuticals
• 8.4. Personal Care & Cosmetics
• 8.5. Others

9. GLOBAL CALCIUM GLUCONATE MARKET BY GEOGRAPHY

• 9.1. Introduction
• 9.2. North America
  • 9.2.1. USA
  • 9.2.2. Canada
  • 9.2.3. Mexico
• 9.3. South America
  • 9.3.1. Brazil
  • 9.3.2. Argentina
  • 9.3.3. Others
• 9.4. Europe
  • 9.4.1. Germany
  • 9.4.2. France
  • 9.4.3. United Kingdom
  • 9.4.4. Spain
  • 9.4.5. Others
• 9.5. Middle East and Africa
  • 9.5.1. Saudi Arabia
  • 9.5.2. UAE
  • 9.5.3. Israel
  • 9.5.4. Others
• 9.6. Asia Pacific
  • 9.6.1. China
  • 9.6.2. India
  • 9.6.3. Japan
  • 9.6.4. South Korea
  • 9.6.5. Indonesia
  • 9.6.6. Thailand
  • 9.6.7. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 10.1. Major Players and Strategy Analysis
• 10.2. Market Share Analysis
• 10.3. Mergers, Acquisitions, Agreements, and Collaborations
• 10.4. Competitive Dashboard

11. COMPANY PROFILES

• 11.1. Spectrum Laboratory Products, Inc.
• 11.2. Thermo Fisher Scientific
• 11.3. Noah Technologies Corporation
• 11.4. Global Calcium Pvt Ltd
• 11.5. Merck KGaA
• 11.6. Tomita Pharmaceutical Co., Ltd
• 11.7. Shandong Xinhong Pharmaceutical Co., Ltd
• 11.8. AdvaCare Pharma
• 11.9. Paul Lohmann GmbH & Co. KGaA
• 11.10. Jiaan Biotech
• 11.11. Fresenius Kabi

12. APPENDIX

• 12.1. Currency
• 12.2. Assumptions
• 12.3. Base and Forecast Years Timeline
• 12.4. Key Benefits for the Stakeholders
• 12.5. Research Methodology
• 12.6. Abbreviations